COMBiNATi
(Hikari Fund’s Portfolio)
[Acquired by Thermo Fisher]
Combinati is developing the Next Generation PCR for Every Lab.
Their bleeding-edge technology enables doctors and researchers to detect & track critical biomarkers
Their bleeding-edge technology enables doctors and researchers to detect & track critical biomarkers